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S U M M A R Y
Objectives: To elucidate clinical andmolecular characteristics of chikungunya fever (CHIK fever) from the
2008–2009 outbreak caused by chikungunya virus (CHIKV) in southern Thailand.
Methods: Three hundred and eighty-one sera from 332 patients with acute febrile illness were tested for
anti-CHIKV IgM antibody by ELISA. A molecular analysis of these sera was performed using a semi-
nested reverse transcriptase polymerase chain reaction (RT-PCR), followed by direct sequencing and
phylogenetic analysis.
Results: One hundred and seventy-nine patients were diagnosed with CHIK fever by molecular analysis
and/or anti-CHIKV IgM antibody detection. Patients diagnosed with CHIK fever were signiﬁcantly older
than controls (mean age 38.8  19 vs. 28.7  18 years, p < 0.0001) and presentedwith arthralgiamore often
than controls. One hundred percent of the sera were positive by RT-PCR, whereas only 10% were positive in
serological tests for anti-CHIKV IgM antibody by ELISA if the serum was obtained during the ﬁrst 4 days of
fever. In contrast, CHIKV-speciﬁc IgM antibody by ELISA was found in 100% of patients, whereas 15% of
patients were positive by RT-PCR if the serumwas obtainedmore than 9 days after the onset of fever. RT-PCR
for CHIKV should be performed if the patients present within the ﬁrst 4 days of fever. Patients presenting
after at least 9 days of fever should be tested for IgM antibody. Based on phylogenetic analysis, the CHIKV
strains isolated belong to African genotypes harboring the E1 A226V mutation, indicating a single origin of
the 2004–2009 CHIKV outbreaks.
Conclusions: The novel CHIKV mutation could potentially modify the epidemiological presentation of
CHIK fever. Early diagnosis of CHIK fever is essential for preventing further massive outbreaks.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Since the initial discovery of chikungunya virus (CHIKV) in
Tanzania, East Africa in 1952–1953,1 knowledge on chikungunya
fever (CHIK fever) has been continuously evolving. In Asia, the ﬁrst
CHIK fever outbreak occurred in Thailand in 1958.2 CHIKV
circulated in the area until 1962–1964.3 Several small outbreaks
occurred sporadically in different areas, but the last outbreak in
Thailand occurred in the mid-1970s. Other CHIK-endemic
countries have faced similar situations. CHIKV virtually disap-
peared for approximately three decades, but more recently has re-
emerged in the form of sudden outbreaks in Africa, the Indian
Ocean, and Asia.* Corresponding author. Tel.: +66 2 256 4909; fax: +66 2 256 4929.
E-mail address: Yong.P@chula.ac.th (Y. Poovorawan).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.01.001Relatively little is known about CHIKV despite its discovery
more than 50 years ago. The disease has received little attention
because it has generally been regarded as self-limiting with few
severe complications. This is currently being reconsidered in the
light of signiﬁcant evidence that neurological complications are
not as uncommon aswas previously believed.4,5 Upon realizing the
severity of recent outbreaks, scientists around the world have
raised signiﬁcant concerns about CHIKV.
The current outbreaks began in Tanzania in 2004 and CHIKV has
subsequently been introduced intomany countries worldwide as a
result of infected humans returning from epidemic areas. CHIKV
was isolated on Reunion Island6 and in India7 during the 2005–
2006 outbreaks. Europe, the USA, and Australia have recently seen
sporadic introduced cases of CHIK fever, especially in travelers
returning from epidemic regions. Italy experienced an outbreak
that affected thousands of people8 resulting from the virus being
introduced by infected international travelers from epidemic
areas9 into the regions where Aedes albopictus is present. Unusualses. Published by Elsevier Ltd. All rights reserved.
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cal involvements such as Guillain–Barre´ syndrome5 have been
reported. Vertical transmission has been observed during these
outbreaks.10
The recognized vector for CHIK fever is the Aedes aegypti
mosquito, with A. albopictus as the secondary vector. Recently,
several countries including Indian Ocean islands,11 Kerala State in
India,12 Gabon,13 and Italy8 have reported A. albopictus as a
potential vector for CHIKV during recent outbreaks. Moreover,
additional molecular virus research performed in the course of
these outbreaks has demonstrated a variant of the early CHIKV
associated with many of the more recent outbreaks. This variant
possesses a mutation from alanine to valine at amino acid position
226 of the E1 envelope glycoprotein gene (E1 A226V muta-
tion).12,14,15 This mutation enhances the ability of the salivary
gland of A. albopictus mosquitoes to become infected and thus
increases the capability of the mosquitoes to transmit the virus to
another host.15
In September 2008, the Department of Disease Control of the
Thai Ministry of Public Health (MOPH) reported an outbreak of 200
cases diagnosed with CHIK fever in southern Thailand near the
border with Malaysia.16 CHIKV was isolated from A. albopictus
mosquitoes trapped in the affected area. The outbreak has not yet
been controlled. So far, thousands of people have been infected.
This study was designed to elucidate the clinical manifestations,
molecular characteristics, and vectors of CHIKV in southern
Thailand in order to facilitate early diagnosis, control this outbreak,
and prevent further outbreaks.
2. Patients and methods
Starting in September 2008, a major CHIK fever outbreak has
occurred in southern Thailand near the Malaysian border, mainly
affecting Narathiwat Province. Patients who presented at the
Narathiwatratchanakharin Provincial Hospital with acute febrile
illness were enrolled in this study. The demographic and clinical
data of these patients were obtained from medical records. The
study was approved by the Ethics Committee, Faculty of Medicine,
Chulalongkorn University for using anonymous specimens for
further investigation upon permission by the directors of
Chulalongkorn Hospital and Narathiwatratchanakharin Provincial
Hospital.
3. Patients
From 332 patients with acute febrile illness, 381 sera were
obtained. Baseline clinical data including the history of present
illness, physical examination, and complete blood count were
obtained by the clinicians at Narathiwatratchanakharin Provincial
Hospital. Chikungunya infection was investigated at the Center of
Excellence in Clinical Virology, Chulalongkorn University, by
serology and molecular virus research. CHIK fever was diagnosed
based on ampliﬁcation of CHIKV RNA by semi-nested reverse
transcriptase polymerase chain reaction (RT-PCR) and/or IgM
antibody detection. Sera were tested for IgM antibodies to CHIKV
by ELISA using commercially available kits (SD BIOLINE, Kyonggi-
do, Korea). Semi-nested RT-PCR was performed to detect CHIKV
RNA. The RT-PCR products speciﬁc for CHIKV were subjected to
direct sequencing.
4. Detection of CHIKV RNA by semi-nested RT-PCR
CHIKV-RNA was extracted from 50 ml of each serum sample by
the guanidium isothiocyanate method as described elsewhere,17
and subsequently reverse-transcribed into cDNA using random
hexamer primers. The cDNA was subsequently ampliﬁed by semi-nested PCR. For the ﬁrst PCR, DVRChkF 50-ACCGGCGTC TACC-
CATTCATGT-30 (nt 10237–10258)18 and CU3-CHIKR 50-
TCGCTRCAGCACACRGCACC-30 (nt 10741–10760) were used as
forward primer and reverse primer, respectively.
The ﬁrst PCR was performed in a thermocycler model 9600
(Perkin Elmer Cetus, Norwalk, CT, USA). Cycling conditions
included initial denaturation at 95 8C for 3 min, followed by 40
ampliﬁcation cycles of 1 min at 95 8C for denaturation, 1 min at
55 8C for primer annealing, 1 min at 72 8C for extension, and
10 min at 72 8C for ﬁnal extension. Then, the semi-nested PCR was
performed by using CU1CHIKF 50-GCATCAGCTAAGCTCCGCGTC-30
(nt 10378–10398) as an inner forward primer. After electrophor-
esis in a 2% agarose gel stained with ethidium bromide, the
expected 532-bp bands were visualized on a UV transilluminator.
5. CHIKV sequencing and genotype characterization
We randomly selected PCR products for sequencing. The PCR
products were puriﬁed using the Perfectprep Gel Cleanup Kit
(Eppendorf, Westbury, NY, USA) according to the manufacturer’s
speciﬁcations and subsequently subjected to 2% agarose gel
electrophoresis in order to ascertain their purity.
To determine the concentration of the ampliﬁed DNA, each
sample was analyzed by absorption at 260 nm in a BioPhotometer
(Eppendorf, Hamburg, Germany). The DNA concentration was
calculated based on the conversion of 1 OD260 being equivalent to
50 g double-stranded DNA. Between 10 and 30 ng/l (3–6 l) of each
DNA sample were subjected to sequencing.
6. Phylogenetic analysis of isolated CHIKV sequences
The sequences were determined by BLAST/FASTA (http://
www.ncbi.nlm.nih.gov) and phylogenetic analysis. The sequences
were edited and assembled using programs CHROMAS LITE v. 2.0
(http://www.technelysium.com.au/chromas_lite.html) and Seq-
Man (DNASTAR, Madison,WI, USA). To investigate the relationship
between CHIKV strains, the un-rooted tree topology based on
multiple alignments of the E1 gene nucleotide sequences and those
of known wild types and mutants from GenBank was established
by the neighbor-joining method calculated with MEGA 3.1 (http://
www.megasoftware.net). Consistency of branching was tested by
bootstrap analysis with 1000 re-samplings of the data usingMEGA
3.1. Multiple protein translation and sequence alignments were
generated with BioEdit version 7.0.1 (http://www.mbio.ncsu.edu/
BioEdit/bioedit.html). The sequences of the isolated strains were
grouped and compared with the corresponding sequences of
CHIKV stored at the GenBank database.
7. Statistical analysis
Variables were summarized including mean and standard
deviations (SD). The relationships between gender, symptoms
(skin rash and arthralgia), and CHIK fever status (positive and
negative) were analyzed by Fisher’s exact test. Differences in age,
body temperature, hemoglobin, and platelets between CHIK
patients and controls were assessed by Student’s t-test. The
statistical analyses were performed with SPSS software version 11
(SPSS Inc., Chicago, IL, USA). p-Values below 0.05 (5%) were
considered statistically signiﬁcant.
8. Results
Of the 332 patients enrolled in the study, 179 patients were
diagnosed with CHIK fever either based on ampliﬁcation by semi-
nested RT-PCR or IgM antibody by ELISA. Of these 179 patients, 125
(70%)werediagnosedwithCHIK fever based on semi-nestedRT-PCR
Table 1
Demographic and clinical data of patients with chikungunya fever and controls
Chikungunya
fever (n=179)
Controls
(n=153)
p-Value
Male:female ratio 78:101 76:77 NS
Age (years) mean SD 38.819 28.718 <0.0001
Rash 6 7 NS
Arthralgia 148 97 <0.0001
Body temperature 38.80.8 38.90.7 NS
Hemoglobin 13.21.7 13.11.9 NS
Platelets 20968 204113 NS
NS, not signiﬁcant.
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ELISA. Fourteen patients (8%) proved positive both by semi-nested
RT-PCRand IgMantibody in the sameserumsample. Therewere101
females and78males, and age ranged from2 to 84 years (mean 38.8
years). A predilection by sex was not noted among patients with
CHIK fever. Patients with CHIK fever were signiﬁcantly older than
patients diagnosed as negative for CHIK fever (control group)
(p< 0.0001). Additional symptoms and laboratory results are
shown in Table 1. Degree of fever and the frequency of skin rash
did not differ between the two groups. However, patientswith CHIK
fever presented with arthralgia more frequently than the control
groupand thiswas statistically signiﬁcant (p< 0.0001). The levels of
hemoglobin, and platelet counts did not differ between patients
with CHIK fever and the control group.
Further analyses revealed that among the 125 patients with
CHIK fever based on semi-nested RT-PCR, 114 (91%) presented
during the ﬁrst 4 days after the onset of fever, whereas only 11 (9%)
presented later than 5 days after the onset of fever. IgM antibody
for CHIKV was detected in the sera from the ﬁrst few days after the
onset of fever and lasted for at least 35 days.
From 49 of 125 patients diagnosed with CHIK fever based on
semi-nested RT-PCR, the second set of sera obtained demonstrated
disappearance of CHIKV and/or seroconversion in the second
specimen in direct relation to duration of fever, as shown in
Figure 1. RT-PCR for CHIKV was 100% positive, whereas the IgM
antibody was detected in only 10% of the specimens if the ﬁrst
serum sample was obtained during days 1–4 of fever (Figure 1).
The percentage of positive RT-PCR for CHIKV was markedly
decreased when the specimens were obtained from day 5 onwards
following the onset of fever. By days 9–12 of fever, all patientswere
positive for IgM antibody against CHIKV, whereas only 15% of
patients were positive by RT-PCR.
9. Molecular virus characterization
All isolated CHIKV strains that were randomly selected for
sequencing were submitted to the GenBank database underFigure 1. Percent of paired sera specimenswith chikungunya virus (CHIKV) positive
by semi-nested RT-PCR or anti-CHIKV IgM in relation to duration of fever.accession numbers FJ882857–FJ882922. All CHIKV strains from
this outbreak were closely related to the African genotypes and to
strains isolated from the 2007 outbreaks in India (99–100%), as
shown in Figure 2, implying a common origin.12 The nucleotide
sequence homology shared among all CHIKV strains isolated in this
study was more than 99%. Moreover, all displayed the E1 A226V
mutation. However, the homology between the sequences of
strains isolated from this study and those from the previous
outbreaks in Thailand (1962–1996) was only 92–93%, suggesting
that CHIKV was imported to Thailand and caused the 2008
outbreak.
10. Discussion
Based on the results of this study, the only signiﬁcant sign for
CHIK feverwas arthralgia, consistentwith the name coined in 1955
‘chikungunya’, which means ‘that which contorts or bends up’.1,19
However, the degree of fever and the incidence of skin rash did not
differ between patients with CHIK fever and the control group. No
predilection by sex was observed among patients with CHIK fever.
Unlike in dengue hemorrhagic fever, patients with CHIK fever did
not develop signiﬁcant hemoconcentration or thrombocytopenia.
After the ﬁrst diagnosis and outbreak of CHIK in Thailand in 1958,1
an estimated 40 000 people were infected during the 1960 s due to
heavy infestation by A. aegypti in the water containers ubiquitous
in Thai households.2 CHIKV transmission nearly disappeared from
Thailand during the mid 1970 s despite the continued presence of
the presumed vectors in the area. This observation is supported by
the report of Burke et al.,20 that lack of exposure to CHIKV after the
1970 s led to low baseline protective immunity and thus, rendered
the population susceptible to the virus. Hence, antibodies to CHIKV
were rare in Bangkok children born after 1976. Several small
sporadic outbreaks were reported from Khon Kaen (July 1991),
Nakorn Si Thammarat (July 1995), and Nong Khai (August 1995)
provinces in the 1990s.21 However, the virus re-emerged as a
major epidemic in 2008. The reasons for the disappearance of
CHIKV, despite the presence of the appropriate vector, have not
been adequately explained, although it seems likely that suitable
reservoir hosts other than humans may not have been present
during the period of apparent ‘silence’.
Demographically, the mean age of patients presenting with
CHIK fever in this study was approximately 40 years, suggesting
that adults had rarely been exposed to CHIKV before and did not
have protective antibodies. Watanaveeradej et al.22 reported high
seroprevalence of antibodies to CHIKV by hemagglutination
inhibition of up to 45% in Thai pregnant women over the age of
35 years, although this percentage positivity in this particular
group of women does not ensure that herd immunity is sufﬁcient
to protect the population against an incoming strain of virus. Thus,
the Thai population may still be susceptible to CHIKV. Similarly, a
report from Sri Lanka, another CHIK fever endemic country,
demonstrated no evidence of antibodies against CHIKV before the
most recent outbreak, making the population susceptible to the
virus.23
Serology and molecular virus research are rapid and accurate
methods for diagnosis of CHIK fever. During the ﬁrst 4 days of fever,
viremia was detected by semi-nested RT-PCR in 100% of patients,
whereas IgM antibody was detected in approximately 10% of
patients. The chance of having viremia decreased as the IgM
antibody developed. During days 9–12 of fever, the IgM antibody
developed in all patients, while CHIKV was still detectable by the
semi-nested RT-PCR in approximately 15% of patients.
CHIKV has been known to be transmitted by A. aegypti
mosquitoes. Recent in vitro experimental studies have shown that
A. albopictus is essentially an important vector for CHIKV.15,24 CHIKV
has been isolated from A. albopictus mosquitoes trapped during
Figure 2. Phylogenetic tree showing the relationship between chikungunya virus (CHIKV) strains using un-rooted tree topology based onmultiple alignments of the E1 gene
nucleotide sequences and those of known wild types and mutants from GenBank, established by the neighbor-joining method calculated with MEGA 3.1. Open circles
represent CHIKV strains isolated from this study.
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southern Thailand.25 According to the study presented here, CHIKV
isolated fromthisoutbreakharbors thenewmutation (A226V) in the
E1envelope glycoprotein gene similar to that found in those isolated
during the recent outbreaks in other countries.26 This mutation
signiﬁcantly increases CHIKV transmissibility to and by A. albopictus
mosquitoes, which provides a selective advantage over infection in
A. aegypti.10,23 In Thailand, A. albopictus is abundant in the para
rubber tree (Hevea brasiliensis) plantation area, where people
residing in southern Thailand work as rubber tappers. Thus, vector
control is evidently one of the most essential means to reduce the
risk of further outbreaks of CHIKV in southern Thailand.The novel CHIKV mutation and worldwide dispersal of A.
albopictus mosquitoes9,11–13,25 could potentially modify the
epidemiological presentation of CHIK fever. According to the
study presented here, the isolated CHIKV strains harbor the E1
A226V mutation. Moreover, A. albopictus is not only found in
tropical regions; this species is also now becoming established in
more temperate climates. Thus, as suggested previously,15,25,26
CHIKV has the potential to present a threat to public health even in
developed countries. Healthcare providers should be made aware
that in tropical regions and potentially in temperate regions where
A. albopictus has become established, CHIKV could present a
serious threat. A state of awareness should be communicated to
P. Rianthavorn et al. / International Journal of Infectious Diseases 14S (2010) e161–e165 e165the relevant medical personnel in hospitals, especially when
patients present with high-grade fever accompanied by severe
arthralgia. Conﬁrmation by speciﬁc diagnosis is relatively
straightforward. All commercial trafﬁc entering the country should
be screened for the presence of all stages of A. albopictus.
Implementation of this measure requires a highly organized
infrastructure with well-trained personnel.
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